Developing Novel Therapies: Uncovering the PF Connectome

Time: 9:30 am
day: Day One


  • Understanding the PF Connectome and what it means for IPF drug developers
  • Utilizing artificial intelligence and cutting-edge, single cell profiling technologies to accelerate implementations of novel precision therapies in PF
  • Creating a dynamic, public atlas of cell and compound fibrosis specific signatures